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Objectives: The purpose of this study was to evaluate the consequences on patient selection and on early and midterm
results of the learning curve of a surgical team performing laparoscopy-assisted surgery in the treatment of severe
aortoiliac occlusive disease (AIOD).
Patients and Method: Between January 1998 and June 2003, 58 patients (53 men, 5 women; mean age, 59.5 years [range,
37-76 years]) were included in a prospective study and underwent a laparoscopy-assisted aortofemoral reconstruction
with graft implantation through a 5-cm to 8-cm minilaparotomy. Fifty-one patients (88%) had claudication (category 2
or 3, Rutherford classification), and seven patients (12%) had tissue loss; at presentation they had TransAtlantic
Inter-Society Consensus C (n  24, 41.4 %) or D (n  32, 55.2%) iliac lesions, and the last 2 patients (3.4%) had severe
aortic lesions. Perioperative data for the first 29 patients, obtained during the first 34 months of the study (group 1), were
compared with data for the last 29 patients, obtained during the last 32 months of the study (group 2). Follow-up
consisted of clinical examination or duplex scanning, or both, at 1, 3, 6, and 12 months and yearly thereafter, and
computed tomography before discharge and then every 2 years.
Results: One intraoperative surgical conversion (1.7%) was necessary, and two other patients (3.4%) died in the immediate
postoperative period. With experience, initial contraindications such as obesity or suprarenal artery aortic clamping were
eliminated, making it possible to increase the percentage of patients included, from 53.7% during the first 34 months to
90.6% during the last 32 months (P .003). The mean duration of the operative procedure decreased from 285 minutes
in group 1 to 192 minutes in group 2 (P < .001), and the mean duration of aortic clamping decreased from 76.4 minutes
in group 1 to 31.8 minutes in group 2 (P < .001). The number of early repeat interventions was reduced from three
(10.3%) in group 1 to 2 (6.9%) in group 2 (P  NS), and the clinical recovery period decreased from 7 days to 4.5 days
(P .05). During a mean follow-up of 26.7 months (range, 1-66 months) there were 5 repeat surgeries (9%) to treat late
graft occlusion, establishing midterm primary and secondary patency rates of 89.3% and 91%, respectively. No aortic false
aneurysms were detected, and no major amputations were performed.
Conclusion: These preliminary results assess the feasability and the safety of this minimally invasive video-assisted
technique. A short period of postoperative recovery and good midterm patency rate are the two main benefits of this new
surgical option. (J Vasc Surg 2004;39:777-83.)
Compared with conventional surgery, laparoscopic
techniques have gained widespread acceptance in visceral
surgery, because they reduce postoperative trauma and
pain, shorten hospital stay, and lead to both earlier resump-
tion of intestinal function and earlier return to normal
activities. Applyication of laparoscopic techniques to short
series of vascular procedures provides some early bene-
fits.1-4 However, several questions have been raised con-
cerning the routine use of these less aggressive techniques
in patients with TransAtlantic Inter-Society Concensus
(TASC)5 type C and type D iliac lesions: How many of
these patients are suitable candidates? Is the effect of the
learning curve able to shorten the length of the procedure?
Are early morbidity and mortality rates comparable to those
of conventional and endovascular surgery? What is the
midterm patency rate?
Data from large series of patients are now required if
the technique is to be described as an alternative to other
surgical techniques, and as a means of justifying the several
month training program with living animals or human
cadavers that is necessary before performing totally laparo-
scopic or, to a lesser degree, laparoscopy-assisted tech-
niques. In particular, the real early and late benefits for
patients, plus the difficulties for vascular surgeons, must be
evaluated. In a recent article6 we demonstrated the favor-
able consequences on patient selection and on early and
midterm results during our learning curve performing lapa-
roscopy-assisted surgery in the treatment of abdominal
aortic aneurysm (AAA). Another study was conducted in
our department to determine the advantages of this tech-
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nique for patients with severe AOID. The lessons learned
from our first 58 patients are presented here.
PATIENTS AND METHOD
Between January 1998 and June 2003, 102 patients
underwent laparoscopic aortic reconstruction in our de-
partment, after inclusion in a prospective study approved by
the Commission Consultative de Protection des Personnes
dans la Recherche Biome´dicale of the University of Mar-
seilles. These procedures were performed for AAA repair in
41 patients and severe AIOD in 61 patients, including 3
patients in whom thoracoscopic bypass was performed be-
tween the descending thoracic aorta and the femoral arter-
ies. Only the 58 patients who underwent laparoscopic
abdominal aortic reconstruction to treat AIOD were in-
cluded in the present study.
Patient demographic data were recorded prospectively.
Systematic examinations included a clinical examination;
ankle-brachial index (ABI) test; duplex scanning of the
aorta, lower limbs, and cervical arteries; angiography or
magnetic resonance angiography of the aorta and lower
limbs; and computed tomography (CT). All patients un-
derwent a preoperative cardiopulmonary examination that
included echocardiography, functional respiratory evalua-
tion, and determination of arterial blood gas levels.
Surgical technique. The surgical technique has been
described,6,7 and only the main points are discussed here.
Administration of general anesthesia was similar in all pa-
tients, and no patients received epidural anesthesia during
or after the procedure. With the patient placed supine on
the operating table with a pillow under the lumbar region,
groin incisions were made first with dissection free of the
femoral bifurcations. The first 12-mm trocar, inserted
through an umbilical incision with an open technique,
enabled the abdominal cavity to be visualized and insuf-
flated with carbon dioxide to a pressure of 8 mm Hg. Three
additional 12-mm ports used for the insertion of a 30-
degree viewing laparoscope and the instruments (scissors,
forceps, needle holder) were placed in triangulation in the
left flank. The table was temporarily tilted to a 25-degree
Trendelenburg position, with 5-degree to 10-degree right
lateral decubitus position, and the bowel was gathered
within the right part of the abdomen. It was then possible
to place the laparoscopic intestinal retractor (Fig), with
direct introduction of the distal part of a 3-mm metallic rod
through the abdomen wall, which was placed secondarily to
follow the mesenteric root. Its proximal external part was
then fixed to the operating table. A 12 25-cm net, with a
2-cm lapel sewn along one of its long edges, was placed in
the abdomen through a trocar. The lapel was then slipped
around the metallic rod to maintain the net on the floor of
the abdominal cavity. The net was then applied to the
bowel, and fixed with three to four threads to the right part
of the abdomen wall, keeping the intestine out of the
working area. It was then possible to reduce the Trendelen-
burg and right lateral positions of the operating table to 5
degrees. The retroperitoneum overlying the anterior wall of
the aorta was opened with standard technique. The anterior
and lateral walls of the aorta were dissected from the left
renal vein to the area located just below the origin of the
inferior mesenteric artery (IMA), for placement of a spe-
cially designed distal laparoscopic clamp (B/Braun-Aescu-
lap, Tuttlingen, Germany), which also allowed clamping of
the infrarenal lumbar arteries. A proximal laparoscopic aor-
tic clamp was introduced, with video vision, into the ab-
dominal cavity through a separate 10-mm incision without
a trocar, and placed below, or sometimes above, the renal
arteries.
When the laparoscopic dissection was completed, all
trocars were removed, and a 5-cm to 8-cm minilaparotomy
midline incision was made at the level of the umbilicus. The
longer incisions were made in obese patients or in case of
suprarenal aortic clamping. Because the laparoscopic intes-
tinal retractor was still in place, only abdominal wall retrac-
tors placed on the self-retaining Omni-Tract (Pilling Weck
Europe, St Faget, France) were used. A heparin bolus (50
IU/kg) was administered intravenously, and the aorta was
clamped, after placement of a releasable laparoscopic clamp
(B/Braun-Aesculap) around the origin of the inferior mes-
enteric artery. The aorta was then opened and, when nec-
A, Diagram shows a laparoscopic intestinal retractor, including a
2.5-mm metallic rod designed to follow the mesenteric root, a 25
 12 polypropylene net with a lapel, and three suspension threads.
B, Intraoperative view.
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essary, clots were removed. In most cases a conventional
end-to-side aortoprosthetic anastomosis was performed,
with direct vision. After aortic declamping and control of
hemostasis, retroperitoneal placement of the prosthetic
limbs was achieved by positioning a conventional Crawford
aortic clamp through the groin incisions, with direct-view
intraabdominal control and control with introduction of a
finger through the minilaparotomy. The distal anastomoses
were then made conventionally on the femoral arteries.
Finally, the retroperitoneum was closed with a running
suture, and the port sites, minilaparotomy, and groin were
closed with standard technique.
Study design. For the surgical procedure and early
postoperative period, variables recorded included operative
and clamping duration, suprarenal or infrarenal aortic
clamping site, need for blood transfusion, dates of oral
feeding and mobilization, and postoperative length of hos-
pital stay. In our protocol all patients had to stay at least the
first postoperative night in the intensive care unit. Before
discharge, CT was performed systematically. Inasmuch as
postoperative discharge was sometimes postponed because
of delay in finding a place in a convalescent home, as
requested by certain patients, we considered the day of
clinical recovery as corresponding to the patient’s ability to
walk alone all the way along the corridor of our depart-
ment. To evaluate the effect of the learning curve on
perioperative parameters, data for the first 29 patients
(group 1), who underwent treatment during the first 34
months of the study, were compared with data for the last
29 patients (group 2), who underwent treatment during
the last 32 months of the study.
Follow-up consisted of physical examination by a phy-
sician in our department at 1, 3, 6, and 12 months and
yearly thereafter; duplex scanning at 1, 6, and 12 months
and yearly thereafter; and CT before discharge and yearly
thereafter. Angiography was performed during follow-up
when other arterial lesions were to be treated surgically.
Data obtained at a follow-up physical examination included
delayed surgical complications, such as bypass graft occlu-
sion, walking status, incision hernia, and gastrointestinal
transit. For each nonphysical examination, each anastomo-
sis and the whole prosthesis were systematically analyzed by
medical specialists to detect false aneurysm, anastomotic
stenosis, and bypass graft occlusion or malposition.
Statistical analysis. Comparison between the two
groups of patients was made with the 2 test, with or
without Yates continuity correction, or the Mann-Whitney
U test when appropriate. P  .05 was considered signifi-
cant. Statistical analysis was performed with the computer
program SPSS 10.1 for Windows (SPSS, Chicago, Ill).
RESULTS
Over 66 months, from January 1998 to June 2003, 58
patients (53 men, 5 women; mean age, 59.5 years [range,
37-76 years]) were prospectively included in our study.
During the same period 190 additional patients were re-
ferred to us with symptomatic AIOD: aortoiliac percutane-
ous transluminal angioplasty (PTA) with or without stent-
ing for TASC A or B, and sometimes C, iliac lesions was
performed in 79 patients (41.6 %); 108 patients (56.8%)
with TASC C and D iliac lesions underwent anatomic (n
61) or extra-anatomic (n 47) open surgical bypass; and 3
patients (1.6%) underwent thoracoscopic thoracofemoral
bypass. The 28 patients who underwent open aortobifemo-
ral bypass during this period were not included, because of
emergent AIOD repair (n  1), severe aortic calcifications
(n  6), class IV of the American Society of Anesthesiolo-
gists (ASA) classification (n 7), hostile abdomen (n 9),
obesity (n  2), suprarenal artery aortic clamping (n  2),
and retroperitoneal venous anomalies (n  1). However,
inasmuch as some of these exclusion criteria (obesity,
scheduled suprarenal artery aortic clamping, retroperito-
neal venous anomalies [Table I]) were abandoned during
the inclusion period for group 2, the proportion of patients
included rose from 53.7% (29 of 54 patients) during the
first 34 months to 90.6% (29 of 32 patients) during the last
32 months (P  .0003).
Preoperative data. The indications for treatment
were claudication in 51 patients (88%) (Rutherford classi-
fication: grade I, category 2, 6 patients; grade I, category 3,
45 patients) and tissue loss in 7 patients (12%) (grade III,
category 5; P .003). Mean preoperative ABI was 0.42
11. Twenty-four patients (41.4%) had TASC C iliac lesions,
and 32 patients (55.2%) had TASC D iliac lesions; the last 2
patients (3.4%) had emboligenic aortitis, and aortic stenosis
caused by a large atherosclerotic calcified plaque, respec-
tively. In addition, four patients (9%) had an AAA with a
diameter of less than 40 mm combined with severe iliac
lesions, which were treated simultaneously. Ten patients
(17%) had a history of failed iliac PTA (n  6), crossover
bypass (n  1), or both (n  3).
Patient demographic data and preoperative ASA classi-
fication were comparable in groups 1 and 2 (Table II),
except for significant worsening of preoperative symptoms
(P .003) and severity of the aortoiliac lesions (P .1) in
group 2. In the whole series, 14 patients (24%) underwent
previous abdominal surgery (appendectomy in 7, prosta-
tectomy in 2, and sympathectomy, bladder reconstruction,
left-sided nephrectomy, hysterectomy, and cholecystec-
tomy, 1 each).
Table I. Modification of exclusion criteria during study
of laparoscopic-assisted aortofemoral bypass to treat
aortoiliac occlusive disease
Permanent exclusion criteria
Emergent AIOD restoration
Severe aortic calcifications
Class IV of the American Society of Anesthesiologists
classification
Hostile abdomen
Previous exclusion criteria abandoned with experience
Obesity (BMI 30)
Suprarenal artery aortic clamping
Concomittant renal (ostial) or inferior mesenteric artery
restoration
Retroperitoneal venous anomalies
AIOD, Aortoiliac occlusive disease; BMI, body mass index.
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Intraoperative data (Table III). Fifty-two patients
(89.7%) underwent aortobifemoral bypass (25 in group 1;
27 in group 2), 4 patients (6.9%) underwent aorto-
monofemoral bypass (group 1); end-to-side aortopros-
thetic anastomosis was performed in 54 patients (93.1%),
and end-to-end anastomosis in 4 patients (6.9%). One
patient (1.7%) had an aortoaortic tube graft (group 2),
because of emboligenic aortitis; and one patient (1.7%)
underwent aortic endarterectomy with Dacron patch
(group 2). In one of our first patients intraoperative con-
version (group 1) was necessary, owing to diffuse hemor-
rhage, followed by an uneventful recovery.
Nine patients (15.5%) underwent an additional intra-
operative procedure (three in group 1, six in group 2):
bifurcation femoral refection (n  3), desinsertion of a
previous crossover bypass (n  2), and direct reimplanta-
tion of the IMA in the left prosthetic limb (n  2). One
patient underwent femoropopliteal bypass during the same
operation (group 2), and one patient underwent PTA and
stenting of the superficial femoral artery (group 1). In five
Table II. Patient demographic characteristics, surgical indications, and preoperative anesthesiologist classification
Group 1
(first 29 patients)
Group 2 (last 29
patients)
Pn % n %
Age (y) 58.8  10 60  8 .60
Sex (M/F) 25/4 28/1 .35
Obesity (BMI 30) 1 3.4 4 13.8 .35
Hypertension (%) 12 41 11 38 1
Diabetes (%) 2 6.9 9 31 .04
Hyperlipidemia (%) 19 65.5 11 38 .06
Ischemic heart disease (%) 5 17.2 8 27.5 .12
COPD (%) 12 41 13 44.8 1
Renal dysfunction (%) 0 4 13.8 .12
Smoking (%) 22 76 22 76 .76
Preoperative symptoms*
Claudication, category 2 (%) 5 17.2 1 3.4 .003
Claudication, category 3 (%) 24 82.7 21 72.4
Tissue loss, category 5 (%) 0 7 24.1
Aortoiliac lesions†
TASC C iliac lesions (%) 17 58.6 7 24.1 .01
TASC D iliac lesions (%) 12 41.4 20 69
Aortic lesions (%) 0 2 6.9
ASA classification
Class I (%) 10 34.5 6 20.7 .29
Class II (%) 16 55 16 55
Class III (%) 3 10.3 7 24.1
BMI, Body mass index; COPD, chronic obstructive pulmonary disease; TASC, TransAtlantic Inter-Society Concensus; ASA, American Society of Anesthesi-
ologists.
*Rutherford classification.
Table III. Our learning curve: Modification of preoperative, intraoperative, and early postoperative parameters between
group 1 (first 29 patients) and group 2 (last 29 patients) who underwent laparoscopy-assisted repair of severe aortoiliac
occlusive disease
Group 1 Group 2
Pn % n %
Preoperative parameters
Aortic calcification 50%* 4 13.8 7 24.1 .50
Aortic ectasia 2 6.9 1 3.4 1
Retroperitoneal venous anomalies 0 1 3.4 1
Intraoperative parameters
Operative duration (min) 285  67 192  30 .001
Clamping duration (min) 76.4  52 31.8  15 .001
Aortic clamping above renal arteries 0 5 17.2 .07
Early postoperative parameters
Repeat interventions 3 10.3 2 6.9 .22
Postoperative death 1 3.4 1 3.4 1
Blood transfusion 6 20.6 2 6.9 .02
Clinical recovery (d) 7 5.8 4.5 1.8 .05
*Aortic calcifications involving 50% of proximal neck circumference.
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group 2 patients (17.2%) the proximal aortic clamp was
positioned above the renal arteries.
Mean operative duration was 238 minutes (range, 140-
420 minutes), decreasing from 285 minutes in group 1 to
192 minutes in group 2 (P  .001). Mean aortic clamping
duration was 54 minutes (range, 15-170 minutes), decreas-
ing from 76.4 minutes in group 1 to 31.8 minutes in group
2 (P  .001).
Early postoperative data. Two early deaths (3.4%)
occurred (one in each group), from myocardial infarction at
postoperative day 1, and visceral ischemia at day 6,
respectively.
Five patients (8.6%) underwent early repeat interven-
tions, including three (10.3%) in group 1 and two (6.9%) in
group 2: leakage on the proximal anastomosis (day 1)
required direct hemostasis performed through the mini-
laparotomy; one limb graft occlusion (day 9) from severe
femoral bifurcation disease was treated with thrombec-
tomy; an occlusion of the superficial femoral artery (day of
surgery) was treated with recanalization with placement of
a stent graft; one popliteal embolization required embolec-
tomy (day of surgery); and in 1 patient a left ureteral injury
(day 7) complicated by a urinoma was treated through a
flank incision. No other complications, such as cardiac or
pulmonary problems, were recorded in this series.
Eight patients (13.7%) required blood transfusions,
including six in group 1 and two in group 2 (P  .02).
According to our protocol, the time spent in the intensive
care unit was limited to the first postoperative night for all
patients but four (group 1), who stayed 8, 3, 2, and 2 days,
respectively, because of surgical repeat interventions.
All but 10 patients (82%) tolerated oral feeding on the
second postoperative day, and 33 patients (59%) could be
mobilized the same day.
Mean postoperative hospitalization for survivors was
7.5 days (range, 3-32 days), with a nonsignificant decrease
between group 1 (8.2 days; range, 5-32 days) and group 2
(6.8 days; range, 3-13 days). The mean clinical recovery
period after the procedure was 5.7 days (range, 3-30 days),
with 39 patients (67%) discharged between postoperative
days 3 and 5 and with a significant decrease between group
1 (7 days) and group 2 (4.5 days; P  .05). One-month
primary and secondary patency rates were 98.3% and 100%,
respectively, as calculated with actuarial methods.8
Midterm results. One patient (1.8%) was lost to fol-
low-up during a mean of 26.7 months (range, 1-66
months). The 55 remaining patients were monitored with
132 physical examinations (2.4 per patient; range, 1-8 per
patient), 101 duplex scanning procedures (1.8 per patient;
range, 1-5 per patient), 72 CT procedures (1.3 per patient;
range, 1-3 per patient), and angiography in 8 patients (3 in
group 1, 5 in group 2). Four patients (7.3%) with a patent
aortobifemoral bypass underwent unilateral (n  3) or
bilateral (n  1) femoropopliteal bypass at 3, 5, 7, and 19
months, respectively. Two patients (3.6%) with a patent
bypass graft died during follow-up, from unrelated causes
(hepatic insufficiency and pulmonary insufficiency, respec-
tively), at 7 and 13 months. The mean postoperative ABI at
26.7 months was 0.81  12.
Five patients (9%) had complications related to the
bypass graft during follow-up: one aortobifemoral bypass
occlusion at 3 months after surgery was treated with an-
other open aortobifemoral bypass, and three limb graft
Table IV. Life table primary patency
Time of event
(mo)
No. at
risk at
event
No. of
events Withdrawn
Failure
rate
Cumulative
patency rate SE
0-1 58 1 3 0.017 98.3 1.68
1-3 54 0 2 0.000 98.3 1.74
3-6 52 2 5 0.040 94.36 3.10
6-9 45 0 5 0.000 94.36 3.34
9-12 40 0 1 0.000 94.36 3.54
12-15 39 1 2 0.026 91.90 4.18
15-18 36 1 3 0.028 89.3 4.86
Table V. Life table secondary patency
Time of event
(mo)
No. at risk
at event
No. of
events Withdrawn
Failure
rate
Cumulative
patency rate SE
0-1 58 0 3 0.000 100 0
1-3 55 0 2 0.000 100 0
3-6 53 2 5 0.039 96.10 2.60
6-9 46 0 5 0.000 96.10 2.79
9-12 41 0 1 0.000 96.10 2.96
12-15 40 1 2 0.025 93.70 3.71
15-18 37 1 3 0.028 91.00 4.48
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occlusions due to intimal hyperplasia were noted at 5, 15,
and 15 months, respectively, which were treated with a
crossover in one case, an axillofemoral bypass in another
case, and thrombectomy with angioplasty of the common
femoral artery in the third case. One last patient, with severe
intimal hyperplasia responsible for a limb graft occlusion
with tight stenosis of both the proximal aortic anastomosis
and the contralateral femoral anastomosis, was treated with
a thoracoscopic thoracobifemoral bypass, with interposi-
tion of a vein patch on both femoral anastomoses.
One large isolated femoral pseudoaneurysm was noted
at 2 months, and was treated surgically, followed by un-
eventful recovery. Another small femoral pseudoaneurysm
discovered at 65 months and two asymptomatic incision
hernias on the minilaparotomy are still under surveillance.
No late aortic false aneurysm was detected, and no late
amputation was performed.
Primary and secondary patency at 26.7 months was
89.3% and 91%, respectively, as calculated with actuarial
methods (Tables IV and V).8
DISCUSSION
Since the first laparoscopic aortobifemoral bypass re-
ported by Dion et al in 1993,9 several short series have
reported the feasibility of using different laparoscopic or
laparoscopy-assisted techniques.1-4 Barbera et al2 pre-
sented a series of 17 patients who underwent laparoscopic
transperitoneal aortic reconstruction in a mean time of 262
minutes (range, 150-450 minutes), with three intraopera-
tive conversions. In 1998 Kolvenbach et al10 showed that
laparoscopic-assisted aortic surgery enabled a smaller inci-
sion and reduced surgical trauma, as reflected by a signifi-
cant decrease in interleukin levels, when compared with
conventional surgical techniques. They then proposed the
use of the HandPort device (Smith & Nephew Surgical,
Andover, Mass), which enabled the surgeon to use the
nondominant hand while maintaining the pneumoperito-
neum; this allowed the vascular surgeon to maintain the
sense of touch, particularly when assessing the degree of
aortic calcification, and to perform the aortoprosthetic
anastomosis safely with use of conventional instruments.11
After several experimental studies on living animals and
human cadavers,7,12,13 we began a prospective study in
1998,14 and we present here what is, to our knowledge, the
largest series of laparoscopy-assisted reconstructions be-
cause of severe AIOD. In our opinion, the technique we
present has several advantages over other minimally inva-
sive techniques: a transperitoneal approach provides a large
work space, and makes direct dissection of the infrarenal
aorta possible, with good access to both sides of the aorta
and the right iliac artery; video assistance enables complete
exploration of the abdominal cavity at the beginning of the
procedure, and provides magnification of each detail dur-
ing the dissection; the laparoscopic intestinal retractor
maintains the bowel out of the aortic area during the
laparoscopic dissection and while performing the aorto-
prosthetic anastomosis, and it is then possible to keep the
patient in a regular decubitus position and to decrease the
pneumoperitoneum pressure to 8 mm Hg; performing the
aortic anastomosis through a 5-cm to 8-cm minilapa-
rotomy enables the surgeon to keep tactile sense, to use
conventional instruments, and to maintain the mean aortic
clamping time close to that of conventional open repair
(31.8 minutes in group 2). As we have mentioned for
laparoscopic AAA repair,6 developing our experience has
enabled us to progressively include in this technique pa-
tients with what were previously considered contraindica-
tions (obesity, scheduled suprarenal aortic clamping) and
to significantly reduce the duration of the procedure and
clamping. In our routine practice, it is now possible to
propose this minimally aggressive technique to a large
majority of patients with TASC C or D iliac lesions, offering
them good postoperative comfort, a short recovery period,
and good midterm patency rates. It is not without interest
to mention that patients with permanent contraindications
to this technique (hostile abdomen, severely calcified aorta)
can also undergo laparoscopic treatment with a thoraco-
scopic thoracofemoral bypass.
To determine whether our technique can be consid-
ered a third means of treating severe AIOD, we reviewed
the literature and compared our results with those of con-
ventional and endovascular surgery (Table IV). The mor-
Table VI. Comparative analysis between single-center studies concerning treatment of severe aortoiliac occlusive disease
Author
No. of
patients
Early complications (%)
Midterm patency (%)
Mortality Morbidity
Primary Secondary
n month n month
Conventional surgery
Nevelsteen et al (1991) 869 4.5 20 92 24 96
Poulias et al (1992) 1000 3.3 19.8 87 36
Passman et al (1996) 139 1 19.4 90 24
Endovascular surgery
Nevelsteen et al (1997) 24 9 18 85 12 95
Uher et al (2002) 73 0 10 69 36 81
Rzucidlo et al (2003) 35 3 3 70 12 88
Laparoscopy-assisted surgery
Present series 58 3.4 8.6 89 26 91
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tality in the present series is equivalent to that of conven-
tional surgery,15-17 but both early morbidity, because of
the absence of respiratory and cardiac complications, and
the period of clinical recovery compare favorably. On the
other hand, the results with iliac angioplasty and stenting
for treatment of diffuse or multisegment iliac occlusive
disease have not been promising, as noted by Powell et al,18
who showed that in a subgroup of patients with diffuse iliac
occlusive disease also involving the external iliac arteries,
primary and secondary patency rates after stent treatment
were 30% and 53%, respectively, at 12 months. This ex-
plains why the TransAtlantic Inter-Society Concensus doc-
ument recommends that TASC C and D disease is best
treated with open revascularization.5 However, new endo-
vascular stent grafts can be used to treat extensive AIOD
with good early results.19-21 Rzucidlo et al19 reported
primary and secondary patency rates at 1 year of 70% and
88%. In 53% of their patients, however, a concomitant
common femoral endarterectomy was performed. The
long-term outcome will be an important parameter of
choice between the various techniques, and our prelimini-
ary midterm patency rates seem equivalent to those of
conventional surgery.
This study confirms that it is possible to perform aor-
toprosthetic anastomosis through a minilaparotomy of
quality similar to that of a large incision, provided the bowel
is kept out of the way and once the abdominal aorta has
been dissected laparoscopically. This technique allows the
patient to receive the same bypass graft as in conventional
surgery, but the procedure is less aggressive. It also means
that during the midterm postoperative period patients who
have undergone a laparoscopy-assisted technique can be
monitored with a simple surveillance program similar to
that in patients who undergo open surgical techniques.
This study, and the one recently published on laparos-
copy-assisted AAA repair,6 are new and important steps on
the way to performing minimally aggressive surgical aortic
restorations. In the litterature, most articles clearly separate
the two subjects. Since the indications (extension of the
aneurysm toward iliac arteries, reimplantation of the IMA),
the technical difficulties (control of lumbar arteries, ability
to perform an aortobiiliac reconstruction through a mini-
laparotomy, different midterm patency rates between the
two aortic diseases), and the discussion (the advantages of
our technique are quite different for AAA repair and for
AIOD, compared with alternative techniques) are different
for these two subjects, we thought it might be confusing to
gather the two populations in the same article. The devel-
opment of new laparoscopic vascular instruments, and es-
pecially laparoscopic aortoprosthetic anastomotic devices,
will surely be the next stage in the move toward totally
laparoscopic procedures for both indications.
CONCLUSION
From our findings, we conclude that insofar as diffuse
AIOD is concerned, the laparoscopy-assisted technique is safe
and reliable for aortofemoral bypass procedures and gives
good midterm results. This is the first large, prospective study
that makes it possible to determine the established benefits of
laparoscopic-assisted surgery. Until new instruments for per-
forming aortoprosthetic anastomoses are available, this tech-
nique remains a suitable approach. Further experience and
randomized trials are nevertheless recommended.
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